Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association

Authors
Glenn N. Levine, Richard A. Lange, C. Noel Bairey-Merz
Publication
Journal of the American Heart Association
6(10):e002218
Abstract

Provides 37 pages of summaries from decades of research concerning how meditation affects heart related functioning (blood pressure, heart rate, etc.)

Abstract

Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits of meditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects ofmeditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research on meditation and cardiovascular risk is warranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-term follow-up, and be performed by those without inherent bias in outcome.

Related Listings
Decreased blood pressure in borderline hyperten...
Authors
Herbert Benson, Bernard A Rosner, Barbara R Marzetta, Helen P Klemchuck
Journal
Journal of Chronic Diseases
·
A prospective investigation was designed to test whether the altered behavior of the regular practice of a relaxation, meditational technique might lower blood pressure in 22 borderline hypertensive subjects. The investigation was unbiased with regard to the presence of antihypertensive agents; subject familiarity with blood pressure measurement or with the observer; observer error; and the effects of blood pressure variability. During the control period, blood pressures averaged 146. […]
Heart Rate Variability and Perceived Stress as ...
Authors
Mutsuhiro Nakao
Journal
Journal of Clinical Medicine
Stress is a term used to define the body’s physiological and psychological reactions to circumstances that require behavioral adjustment [1,2,3], and the relaxation response is a psychophysiological state that is opposite to that of the stress or fight–flight response [4]. A variety of mind/body techniques can be used to elicit a relaxation response and achieve the therapeutic effects associated with reduced blood pressure. For example, researchers at the Cochrane Review [5] investiga […]
Specific Transcriptome Changes Associated with ...
Authors
Manoj K. Bhasin, PhD, John W. Denninger, MD, PhD, Jeff C. Huffman, MD, Marie G. Joseph, BA, Halsey Niles, BA, Emma Chad-Friedman, BA, Robert Goldman, BA, Beverly Buczynski-Kelley, RN, Barbara A. Mahoney, RN, Gregory L. Fricchione, MD, Jeffery A. Dusek, PhD, Herbert Benson, MD, Randall M. Zusman, MD, Towia A. Liebermann, PhD
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]